VISTAGEN THERAPEUTICS, INC. Fair Value Adjustment of Warrants
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2024-03-31, per its 10-K filed 2024-06-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2024-06-11
- VISTAGEN THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2023-03-31 was $600.00.
- VISTAGEN THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2022-03-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2019-12-31 was $826.90K.
- VISTAGEN THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- VISTAGEN THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2023 was $78.00K.
- VISTAGEN THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2022 was $0.00.
| Period end | Fair Value Adjustment of Warrants 1 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-11 | $0.00 10-K · filed 2024-06-11 | ||||
| 2023-12-31 | $0.00 10-Q · filed 2024-02-13 | |||||
| 2023-03-31 | $600.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-11 | $78.00K 10-K · filed 2024-06-11 | $77.40K 10-K · filed 2023-06-28 | |||
| 2022-12-31 | $77.40K 10-Q · filed 2024-02-13 | |||||
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28 | $0.00 10-K · filed 2023-06-28 | ||||
| 2021-12-31 | $0.00 10-Q · filed 2023-02-07 | |||||
| 2021-03-31 | $1.00M 10-Q · filed 2021-08-12 | |||||
| 2020-12-31 | $93.60M 10-Q · filed 2021-08-12 | |||||
| 2019-12-31 | $826.90K 10-Q · filed 2021-02-11 | |||||
| 2014-12-31 | -$314.90K 10-Q · filed 2016-02-16 | -$756.60K derived: sum of 2 quarters · filed 2016-02-16 | -$251.50K 10-Q · filed 2016-02-16 | |||
| 2014-09-30 | -$441.70K 10-Q · filed 2015-11-16 | |||||
| 2013-12-31 | -$620.80K 10-Q · filed 2015-02-17 | -$705.00K derived: sum of 2 quarters · filed 2015-02-17 | -$1.35M 10-Q · filed 2015-02-17 | |||
| 2013-09-30 | -$84.20K 10-Q · filed 2014-11-19 | -$733.50K 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |